The in vitro antimicrobial activities of metabolites from lactobacillus strains on Candida species implicated in Candida vaginitis

Malaysian Journal of Medical Sciences

Volumn 18, Issue 4, 2011, Pages 12-24

  Ogunshe, Adenike A O ^a   Omotoso, Mopelola A ^a   Bello, Victoria B ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Antifungal agents; Antimicrobial agents; Candida; Contraceptives; Lactobacillus; Vulvovaginal Candidiasis

Indexed keywords

2,3 BUTANEDIONE; ANTIFUNGAL AGENT; CLOTRIMAZOLE; DOXYCYCLINE; FLUCONAZOLE; HYDROGEN PEROXIDE; KETOCONAZOLE; LACTIC ACID; LACTOBACILLUS ACIDOPHILUS EXTRACT; LACTOBACILLUS BREVIS EXTRACT; LACTOBACILLUS CASEI EXTRACT; LACTOBACILLUS DELBRUECKII EXTRACT; LACTOBACILLUS FERMENTUM EXTRACT; LACTOBACILLUS JENSENII EXTRACT; LACTOBACILLUS PLANTARUM EXTRACT; METRONIDAZOLE; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; NYSTATIN; TETRADOX; UNCLASSIFIED DRUG;

AGAR MEDIUM; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOSYNTHESIS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG ANTAGONISM; FUNGUS CULTURE; IN VITRO STUDY; INCUBATION TIME; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS FERMENTUM; LACTOBACILLUS JENSENII; LACTOBACILLUS PLANTARUM; NONHUMAN; SPECIES COMPARISON; VAGINA CANDIDIASIS;

EID: 80053504611     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microfora. Rev Infect Dis. 1990;12(5):856-872.
2. Boris S, Suarez JE, Vazquez F, Barbes C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun. 1998;66(5):1985-1989.
3. Onderdonk AB, Delaney ML, Hinkson PL. DuBois AM. Quantitative and qualitative effects of douche preparations on vaginal microfora. Obstet Gynecol. 1992;80(3 Pt 1): 333-338.
4. Kunz J. Causes and consequences of an unbalanced vaginal ecosystem. Praxis (Bern 1994). 1995;84(48):1405-1415.
5. Ogunshe AA, Bakare RA, Fasina N. Microbial pathogens implicated in reproductive health infections in a special treatment clinic in Ibadan, Nigeria. J Fam Repr Health. 2009;3(1):9-17.
6. Maccato ML, Kaufman RH. Fungal vulvovaginitis. Curr Opin Obstet Gynecol. 1991;3(6):849-852.
7. Geiger AM, Foxman B, Sobel JD. Chronic vulvovaginal candidiasis: Characteristics of women with Candida albicans, C. glabrata and no Candida. Genitourin Med. 1995;71(5):304-307.
8. Ono F, Yasumoto S. Genital candidiasis. Nippon Rinsho. 2009;67(1):157-161.
9. Carlson P, Richardson M, Paavonen J. Evaluation of the Oricult-N dipslide for laboratory diagnosis of vaginal candidiasis. J Clin Microbiol. 2000;38(3):1063-1065.
10. Klepser ME. Antifungal resistance among Candida species. Pharmacotherapy. 2001; 21(8 Pt 2):124S-132S.
11. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002;2(2):73-85.
12. Mishra NN, Prasad T, Sharma N, Payasi A, Prasad R, Gupta DK, et al. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung. 2007;54(3): 201-235.
13. Ljungh A, Wadstrom T, editor. Lactobacillus molecular biology: From genomics to probiotics. Norfolk (UK): Caister Academic Press; 2009.
14. Boris S, Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2000;2(5):543-546.
15. Jin L, Tao L, Pavlova SI, So JS, Kiwanuka N, Namukwaya Z, et al. Species diversity and relative abundance of vaginal lactic acid bacteria from women in Uganda and Korea. J Appl Microbiol. 2007;102(4):1107-1115.
16. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Nunes AC, Moreira JL, et al. Analysis of vaginal lactobacilli from healthy and infected Brazilian women. Appl Environ Microbiol. 2008;74(14): 4539-4542.
17. McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol. 2000;49(6):543-552.
18. Osset J, Garcia E, Bartolome RM, Andreu A. Role of Lactobacillus as protector against vaginal candidiasis. Med Clin (Barc). 2001;117(8):285-298.
19. Rogosa M, Sharpe ME. Species differentiation of human vaginal lactobacilli. J Gen Microbiol. 1960;23:197-201.
20. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, et al. In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo fndings. Amer J Clin Nutr. 2001;73(2 Suppl):386S-392S.
21. Kreger-van Rij NJW, editor. The yeasts: A taxonomic study. 3rd ed. Amsterdam (NL): Elsevier Science Publishers; 1984.
22. Ogunshe AAO, Lawal OA, Iheakanwa CI. Effects of simulated preparations of plants used in Nigerian traditional medicine on Candida spp. associated with vaginal candidiasis. J Ethnobot Res Appl. 2009;6:373-383.
23. Tagg JR, McGiven AR. Assay system for bacteriocins. Appl Microbiol. 1971;21(5):943.
24. Horwitz W, editor. Offcial methods analysis of the Association of Offcial Analytical Chemists. 13th ed. Gaithersburg (MD): Association of Offcial Analytical Chemists; 1980.
25. Committee on Specifcation of Food Chemicals Codex of the Committee on Food Protection, National Research Council. Food chemicals codex. 2nd ed. Washington (DC): National Academy of Sciences; 1972.
26. Sobel JD. Vulvovaginal candidosis. Lancet. 2007;368(9577):1961-1971.
27. Mardh PA, Wagstrom J, Landgren M, Holmen J. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database. Infect Dis Obstet Gynecol. 2004;12(2): 91-97.
28. Odds FC. Antifungal agents: Resistance and rational use. In: Gould IM, van der Meer JWM, editors. Antibiotic policies: Theory and practice. Gould IM, van der Meer JWM, editors. New York (NY): Kluwer Academic/Plenum Publishers; 2005. p. 311-330.
29. Panizo MM, Reviakina V, Dolande M, Selgrad S. Candida spp. in vitro susceptibility profle to four antifungal agents. Resistance surveillance study in Venezuelan strains. Med Mycol. 2009;47(2): 137-143.
30. Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents. Drug interactions of systemic antifungal agents. Drug Saf. 1998;18(2):83-97.
31. Eschenbach DA, Davick PR Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989;27(2):251-256.
32. McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol. 2000;49(6):543-552.
33. Martin R Soberon N. Vaneechoutte M, Florez AB, Vazquez, F Suarez JE. Characterization of indigenous vaginal lactobacilli from healthy women as probiotic candidates. Int Microbiol. 2008;11(4):261-266.
34. Kaewsrichan J, Peeyananjarassri K, Kongprasertkit J. Selection and identifcation of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol Med Microbiol. 2006;48(1):75-83.
35. Mijac VD, Dukic SV, Opavski NZ, Dukic MK, Ranin LT. Hydrogen peroxide producing lactobacilli in women with vaginal infections. Eur J Obstet Gynecol Reprod Biol. 2006;129(1):69-76.
36. Klebanoff SJ, Hilier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial fora of the vagina by H O -generating lactobacilli. J Infect Dis. 1991;164(1):94-100.
37. Pascual LM, Daniele MB, Pajaro C, Barberis L. Lactobacillus species isolated from the vagina: Identifcation, hydrogen peroxide production and nonoxynol-9 resistance. Contraception. 2006;73(1):78-81.
38. Chassot F, Camacho DP, Patussi, EV, Donatti L, Svidzinski TI, Consolaro ME. Can Lactobacillus acidophilus infuence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring? Contraception. 2010;81(4):331-335.
39. Wheater DM, Hirsch A, Mattick AT. Possible identity of lactobacillin with hydrogen peroxide produced by lactobacilli. Nature. 1952;170(4328):623-624.
40. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microfora in pregnant women. Obstet Gynecol. 1992;79(3):369-373.
41. Daeschel AM. Antimicrobial substances from lactic acid bacteria for use as food preservatives. Food Technol. 1989;43:91-94.
42. Van den Bergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Revs. 1993;12(1-3):221-237.
43. Lanciotti R Patrignani F, Bagnolini F, Guerzoni ME, Gardini F. Evaluation of diacetyl antimicrobial activity against Escherichia coli, Listeria monocytogenes and Staphylococcus aureus. Food Microbiol.
44. Kaneko T, Waranabe Y, Suzuki H. Enhancement of diacetyl production by a diacetyl-resistant mutant of citrate-positive Lactococcus lactis ssp. lactis 3022 and by aerobic conditions of growth. J Dairy Sci. 1990;73(2):291-298.
45. Kinsman O, Collard AE. Hormonal factors in vaginal candidiasis in rats. Infect Immun. 1986;53(3): 498-504.
46. Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vulvovaginal candidiasis. Contraception. 1995;51(5):293-297.
47. Fidel PL, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun. 2000;68(2):651-657.
48. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol. 2001;185(2):380-385.
49. Apisarnthanarax P, Self SJ, Ramer SG, Montes LF. Oral contraceptives and candidiasis: A review of current data. Cutis. 1974;14:77-82.